Chemring Group Valuation
Is CMN1 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CMN1 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CMN1 (€4.22) is trading below our estimate of fair value (€12.27)
Significantly Below Fair Value: CMN1 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CMN1?
Key metric: As CMN1 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is CMN1's PE Ratio? | |
|---|---|
| PE Ratio | 31.6x |
| Earnings | UK£31.10m |
| Market Cap | UK£981.49m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.2x |
| Enterprise Value/EBITDA | 11.7x |
| PEG Ratio | 1.4x |
Price to Earnings Ratio vs Peers
How does CMN1's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 23.4x | ||
OHB OHB | 12.8x | 11.0% | €894.4m |
FQT Frequentis | 18.5x | 14.9% | €317.1m |
MTX MTU Aero Engines | 23.6x | 10.7% | €16.7b |
RHM Rheinmetall | 38.6x | 29.0% | €26.4b |
CMN1 Chemring Group | 31.6x | 22.2% | €981.5m |
Price-To-Earnings vs Peers: CMN1 is expensive based on its Price-To-Earnings Ratio (31.6x) compared to the peer average (23.7x).
Price to Earnings Ratio vs Industry
How does CMN1's PE Ratio compare vs other companies in the European Aerospace & Defense Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: CMN1 is expensive based on its Price-To-Earnings Ratio (31.6x) compared to the European Aerospace & Defense industry average (24.6x).
Price to Earnings Ratio vs Fair Ratio
What is CMN1's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 31.6x |
| Fair PE Ratio | 18x |
Price-To-Earnings vs Fair Ratio: CMN1 is expensive based on its Price-To-Earnings Ratio (31.6x) compared to the estimated Fair Price-To-Earnings Ratio (18x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €4.30 | €5.66 +31.6% | 3.6% | €5.99 | €5.40 | n/a | 5 |
| Nov ’25 | €4.18 | €5.66 +35.4% | 3.6% | €5.99 | €5.40 | n/a | 5 |
| Oct ’25 | €4.38 | €5.29 +20.9% | 11.1% | €5.69 | €4.01 | n/a | 6 |
| Sep ’25 | €5.00 | €5.28 +5.5% | 11.1% | €5.67 | €4.00 | n/a | 6 |
| Aug ’25 | €4.82 | €5.28 +9.5% | 11.1% | €5.67 | €4.00 | n/a | 6 |
| Jul ’25 | €4.36 | €5.18 +18.8% | 11.1% | €5.65 | €3.98 | n/a | 6 |
| Jun ’25 | €4.68 | €5.03 +7.4% | 11.9% | €5.93 | €3.93 | n/a | 6 |
| May ’25 | €4.40 | €5.06 +15.1% | 11.4% | €5.96 | €4.03 | n/a | 6 |
| Apr ’25 | €4.14 | €5.03 +21.6% | 10.7% | €5.97 | €4.04 | n/a | 7 |
| Mar ’25 | €4.03 | €5.03 +24.7% | 10.7% | €5.97 | €4.04 | n/a | 7 |
| Feb ’25 | €4.08 | €4.91 +20.5% | 11.9% | €5.97 | €4.04 | n/a | 7 |
| Jan ’25 | €3.99 | €4.74 +18.8% | 12.5% | €5.91 | €4.00 | n/a | 7 |
| Dec ’24 | €3.67 | €4.35 +18.7% | 7.6% | €4.92 | €3.95 | n/a | 7 |
| Nov ’24 | €3.15 | €4.41 +40.2% | 7.2% | €4.97 | €3.99 | €4.18 | 7 |
| Oct ’24 | €3.18 | €4.54 +43.0% | 8.8% | €5.12 | €4.02 | €4.38 | 7 |
| Sep ’24 | €3.33 | €4.60 +38.1% | 8.5% | €5.11 | €4.01 | €5.00 | 6 |
| Aug ’24 | €3.24 | €4.58 +41.7% | 8.9% | €5.12 | €4.01 | €4.82 | 6 |
| Jul ’24 | €3.26 | €4.41 +35.3% | 10.4% | €5.14 | €3.74 | €4.36 | 9 |
| Jun ’24 | €3.04 | €4.39 +44.4% | 10.5% | €5.07 | €3.74 | €4.68 | 8 |
| May ’24 | €3.13 | €4.44 +41.9% | 9.0% | €5.00 | €3.82 | €4.40 | 7 |
| Apr ’24 | €3.10 | €4.44 +43.3% | 9.0% | €5.00 | €3.82 | €4.14 | 7 |
| Mar ’24 | €3.30 | €4.31 +30.6% | 10.3% | €4.96 | €3.66 | €4.03 | 8 |
| Feb ’24 | €3.12 | €4.35 +39.4% | 10.2% | €4.99 | €3.69 | €4.08 | 8 |
| Jan ’24 | €3.20 | €4.31 +34.7% | 11.4% | €5.00 | €3.65 | €3.99 | 8 |
| Dec ’23 | €3.44 | €4.40 +27.8% | 11.8% | €5.03 | €3.67 | €3.67 | 8 |
| Nov ’23 | €3.38 | €4.38 +29.5% | 11.8% | €5.01 | €3.66 | €3.15 | 8 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Andritz
€5.2b
Provides plants, equipment, and services for pulp and paper industry, metalworking and steel industries, hydropower stations, and solid/liquid separation in the municipal and industrial sectors in Europe, North America, South America, China, Asia, and internationally.
AZ2
€51.75
7D
0%
1Y
5.3%
Finning International
CA$5.2b
Sells, services, and rents heavy equipment, engines, and related products in Canada, Chile, Bolivia, the United Kingdom, Argentina, Ireland, and internationally.
CIH
CA$25.00
7D
-2.3%
1Y
6.8%
DAIHEN
JP¥172.3b
Manufactures and sells transformers, welding machines, and industrial and clean transport robots.
6NV
JP¥43.40
7D
3.3%
1Y
26.2%